Stockreport

23andMe announces CEO’s intention to pursue a potential take-private

23andMe Holding Co.  (ME) 
PDF SOUTH SAN FRANCISCO, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, has been made [Read more]